A network-based analysis to identify a piRNA-target signature related to colorectal cancer prognosis: in silico and in vitro study
It seems that hsa-piR-487 and hsa-piR-28944 can be considered as a potential biomarker for the diagnosis of CRC. However, it is still necessary to conduct studies with a higher statistical population and measure them in the serum of patients to confirm these results.
Authors
- Mehrdad Hashemi (ORCID: https://orcid.org/0000-0003-0627-6991)
- Fatemeh Nouri (ORCID: https://orcid.org/0000-0002-5315-8923)
- Akram Jalali (ORCID: https://orcid.org/0009-0008-1997-6798)
- Fatemeh Khavari (ORCID: https://orcid.org/0000-0003-2695-4198)
- Ali Reza Soltanian (ORCID: https://orcid.org/0000-0002-7483-3502)
- Rezvan Najafi (ORCID: https://orcid.org/0000-0003-1326-1288)
- Saeed Afshar
Institutions
- Hamedan University of Medical Sciences (IR)
- Islamic Azad University Medical Branch of Tehran (IR)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1007/s12672-025-02373-x
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Hamadan University of Medical Sciences